These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 7434268

  • 1. Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.
    Honey M, Cotter L, Davies N, Denison D.
    Thorax; 1980 Apr; 35(4):269-76. PubMed ID: 7434268
    [Abstract] [Full Text] [Related]

  • 2. Diazoxide in treatment of primary pulmonary hypertension.
    Wang SW, Pohl JE, Rowlands DJ, Wade EG.
    Br Heart J; 1978 May; 40(5):572-4. PubMed ID: 656227
    [Abstract] [Full Text] [Related]

  • 3. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S, Martinez J, Lam W, Levy PS, Rosen KM.
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract] [Full Text] [Related]

  • 4. Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
    Chan NS, McLay J, Kenmure AC.
    Br Heart J; 1987 Feb; 57(2):207-9. PubMed ID: 3814459
    [Abstract] [Full Text] [Related]

  • 5. Diazoxide in primary pulmonary hypertension.
    Klinke WP, Gilbert JA.
    N Engl J Med; 1980 Jan 10; 302(2):91-2. PubMed ID: 7350437
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB, Bambach D, Thompson MJ, Huss P, Fontana ME, Magorien RD, Unverferth DV, Leier CV.
    Ann Intern Med; 1982 Oct 10; 97(4):480-9. PubMed ID: 7125407
    [Abstract] [Full Text] [Related]

  • 8. [Effect of diazoxide on severe pulmonary hypertension].
    Raimondi GA.
    Medicina (B Aires); 1990 Oct 10; 50(3):198-204. PubMed ID: 2130205
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diazoxide in treatment of primary pulmonary hypertension.
    Rubino JM, Schroeder JS.
    Br Heart J; 1979 Sep 10; 42(3):362-3. PubMed ID: 508461
    [No Abstract] [Full Text] [Related]

  • 14. Primary pulmonary hypertension: effects of nifedipine.
    Camerini F, Alberti E, Klugmann S, Salvi A.
    Br Heart J; 1980 Sep 10; 44(3):352-6. PubMed ID: 7426194
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr 10; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 17. Vasodilator therapy for pulmonary hypertension.
    Cotter L, Honey M.
    N Engl J Med; 1980 May 29; 302(22):1260. PubMed ID: 7366683
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diazoxide in the management of severe hypertension.
    Moller BB, Kolendorf K.
    Acta Med Scand; 1975 Nov 29; 198(5):358-8. PubMed ID: 1199811
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.